From April 1, 2022 to June 30, 2022, the company has repurchased 16,100 shares, representing 0.05% for CAD 0.22 million. With this, the company has completed the repurchase of 17,900 shares, representing 0.06% for CAD 0.25 million under the buyback announced on November 4, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.75 CAD | -4.04% | -3.85% | +20.25% |
Apr. 08 | HLS Therapeutics Inc. Announces Reduce-IT Analysis Results Relating the Effects of VASCEPA | CI |
Mar. 14 | Transcript : HLS Therapeutics Inc., Q4 2023 Earnings Call, Mar 14, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.25% | 110M | |
+2.01% | 25.01B | |
+6.40% | 8.16B | |
+2.20% | 8.36B | |
-23.25% | 7.69B | |
+0.73% | 4.53B | |
+21.26% | 4.47B | |
-1.46% | 3.99B | |
-2.68% | 3.88B | |
+22.68% | 3.66B |
- Stock Market
- Equities
- HLS Stock
- News HLS Therapeutics Inc.
- Tranche Update on HLS Therapeutics Inc.'s Equity Buyback Plan announced on November 4, 2021.